Clinical trial

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

NCT05923268

Study summary

ClinicalTrials.gov

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention [99mTc]Tc-G3-(G3S)3C Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-06-04

PhaseNA

Conditions

Breast Cancer Femaleunresolved

Interventions

[99mTc]Tc-G3-(G3S)3CDRUG

Sponsors & collaborators

Tomsk National Research Medical Center of the Russian Academy of Scienceslead sponsor

Mapped research locations

TomskRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05923268 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.